ERBB2 and cancer: The prevalence of chromosome 17 in Her2 and Basal subtypes also correlates with the more aggressive clinical behavior of these cancers, as this region contains key genes involved in DNA repair and cell cycle control, whose dysregulation contributes to rapid tumor development [34,38].